Skip to content

Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02437409
Acronym
ARTESp
Enrollment
115
Registered
2015-05-07
Start date
2013-02-28
Completion date
2015-08-31
Last updated
2017-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Ischemic, Acute

Brief summary

ARTESp is a prospective multicenter study in which the pREset thrombectomy system (phenox GmbH\* Germany) will be examined. The effectiveness, safety and the long-term success when using the pREset to treat acute occlusions of cerebral vessels will be analyzed. \*German: Gesellschaft mit beschränkter Haftung, limited liability company

Detailed description

ARTESp is a prospective multicenter study in which the pREset thrombectomy system (phenox GmbH Germany) will be examined. The effectiveness, safety and the long-term success when using the pREset to treat acute occlusions of cerebral vessels will be analyzed. In this study the market-approved, self-expandable stent retriever (pREset, phenox GmbH, Germany) will be used to achieve a direct flow recovery. The thrombectomy system will be unfolded directly in the vessel occlusion. In a second step, the system and the thrombus will be pulled back into the guide catheter. It is planned to enroll 100 patients at the age of 18 until 85 years, with a NIHSS (National Institutes of Health Stroke Scale) ≥ 8 and ≤ 30. The preconditions for study enrollment are the written consent of the patient or of the legal representative and the fulfillment of all mentioned inclusion and exclusion criteria. Pregnant women are excluded from study participation.The clinical interventions are in accordance with the clinical standard of care for the treatment of this patient population. The mRS (Modified Rankin Scale) on day 30, the NIHSS on day 90 and an imaging procedure on day 90 may be performed by the study site provided that it corresponds to the clinical standards of the study site.

Interventions

DEVICEpREset thrombectomy retriever

Interventional recanalization of acute cerebral vessel occlusions with the pREset thrombectomy system alone or in combination with intravenous or intraarterial thrombolytics (rt-PA).

Sponsors

Phenox GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patient age ≥ 18 and ≤ 85 years. * Patients with acute-onset stroke in the 0-6 hour time window for cerebral onset of symptoms and in angiography with a TICI reperfusion (Thrombolysis in Cerebral Infarction) value of 0 or 1 of at least one major cerebral artery (carotid artery, A. media , anterior cerebral artery, basilar artery, vertebral artery, posterior cerebral artery). * NIHSS (National Institutes of Health Stroke Scale) ≥ 8 * Signed Informed Consent by patient / legal representative to participate in the study.

Exclusion criteria

* Pregnancy * Demarcated infarcted area in the initial Cranial CT or intracranial haemorrhage, * Rapid improvement of neurological symptoms * NIHSS \> 30 * Anticoagulation with warfarin with INR (international normalized ratio) \> 3.0, * Platelets \<30,000, * Glucose \<50mg/dl, * Life expectancy \<90 days

Design outcomes

Primary

MeasureTime frameDescription
Neurological Condition of the Patient90 days after treatmentmodified Rankin Scale (mRS) Neurological Condition is measured by the Modified Rankin Scale (mRS). This scale ranges from 0 - 6: 0 = No symptoms at all; 1. = able to carry out all usual duties and activities; 2. = unable to carry out all previous activities, but able to look after own affairs without assistance; 3. = requiring some help, but able to walk without assistance; 4. = unable to walk without assistance and unable to attend to own bodily needs without assistance; 5. = bedridden, incontinent and requiring constant nursing care and attention; 6. = dead

Secondary

MeasureTime frameDescription
Neurological Condition of the Patient24 to 72 hr after treatmentThe National Institutes of Health Stroke Scale (NIHSS) is a commonly used measure to assess the severity of a stroke. All items are rated and scores are added at the end. A higher score corresponds to a more severe stroke. Assessed are: 1. Level of Conciousness (LOC) (0-3) 1a. LOC Questions (0-2) 1b. LOC Commands (0-2) 2. Best Gaze (0-2) 3. Visual (0-3) 4. Facial palsy (0-3) 5. Motor arm (0-4) 6. Motor leg (0-4) 7. Limb ataxia (0-2) 8. Sensory (0-2) 9. Best Language (0-3) 10. Dysarthria (0-2) 11. Extinction and Inattention (0-2) CLASSIFICATION: 0 No stroke symptoms 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke As published by ninds.nih.gov: http://www.ninds.nih.gov/doctors/NIH\_Stroke\_Scale.pdf
Intracranial Hemorrhage (ICH)24 hr after treatmentIntracranial hemorrhage was assessed via imaging material (e.g. Digital Subtraction Angiography - DSA or CT) as forwarded by the clinical sites.
Time From Groin Puncture to Recanalizationduring intervention, up to 3 hr
Recanalization of the Target Vesselat the end of intervention, up to 3 hroriginal Thrombolysis in Cerebral Infarction score (o-TICI) The TICI scale indicates perfusion of an occluded blood vessel, it is used in angiographic imaging. Grade 0 = no perfusion Grade 1 = Penetration with minimal perfusion. The contrast material passes beyond the area of obstruction but fails to opacify the entire cerebral bed distal to the obstruction for the duration of the angiographic run, Grade 2a = Only partial filling (\<2/3) of the entire vascular territory is visualized, Grade 2b = Complete filling of all of the expected vascular territory is visualized, but the filling is slower than normal, Grade 3 = complete perfusion.
No. of Passages Needed to Reach the Final TICI Score With pREsetduring intervention, up to 3 hr

Countries

Germany

Participant flow

Recruitment details

115 patients started the study, but little by little, 15 patients were excluded/discontinued due to screening failure or withdrawn consent.

Pre-assignment details

No assignment to groups was performed due to single-arm study.

Participants by arm

ArmCount
All Patients
Treated with pREset Thrombectomy Retriever
100
Total100

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScreening failure12
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicAll Patients
Age, Continuous68.3 years
STANDARD_DEVIATION 13.8
Region of Enrollment
Germany
100 participants
Sex: Female, Male
Female
55 Participants
Sex: Female, Male
Male
45 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
24 / 100
serious
Total, serious adverse events
7 / 100

Outcome results

Primary

Neurological Condition of the Patient

modified Rankin Scale (mRS) Neurological Condition is measured by the Modified Rankin Scale (mRS). This scale ranges from 0 - 6: 0 = No symptoms at all; 1. = able to carry out all usual duties and activities; 2. = unable to carry out all previous activities, but able to look after own affairs without assistance; 3. = requiring some help, but able to walk without assistance; 4. = unable to walk without assistance and unable to attend to own bodily needs without assistance; 5. = bedridden, incontinent and requiring constant nursing care and attention; 6. = dead

Time frame: 90 days after treatment

Population: All Patients

ArmMeasureGroupValue (NUMBER)
All PatientsNeurological Condition of the PatientmRS 023 patients
All PatientsNeurological Condition of the PatientmRS 0-152 patients
All PatientsNeurological Condition of the PatientmRS 0-260 patients
All PatientsNeurological Condition of the PatientmRS 3-529 patients
All PatientsNeurological Condition of the PatientmRS 67 patients
All PatientsNeurological Condition of the PatientLost to follow-up4 patients
Secondary

Intracranial Hemorrhage (ICH)

Intracranial hemorrhage was assessed via imaging material (e.g. Digital Subtraction Angiography - DSA or CT) as forwarded by the clinical sites.

Time frame: 24 hr after treatment

Population: All Patients

ArmMeasureValue (NUMBER)
All PatientsIntracranial Hemorrhage (ICH)14 patients
Secondary

Neurological Condition of the Patient

The National Institutes of Health Stroke Scale (NIHSS) is a commonly used measure to assess the severity of a stroke. All items are rated and scores are added at the end. A higher score corresponds to a more severe stroke. Assessed are: 1. Level of Conciousness (LOC) (0-3) 1a. LOC Questions (0-2) 1b. LOC Commands (0-2) 2. Best Gaze (0-2) 3. Visual (0-3) 4. Facial palsy (0-3) 5. Motor arm (0-4) 6. Motor leg (0-4) 7. Limb ataxia (0-2) 8. Sensory (0-2) 9. Best Language (0-3) 10. Dysarthria (0-2) 11. Extinction and Inattention (0-2) CLASSIFICATION: 0 No stroke symptoms 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke As published by ninds.nih.gov: http://www.ninds.nih.gov/doctors/NIH\_Stroke\_Scale.pdf

Time frame: 24 to 72 hr after treatment

Population: All Patients

ArmMeasureValue (MEDIAN)
All PatientsNeurological Condition of the Patient5 NIHSS score
Secondary

No. of Passages Needed to Reach the Final TICI Score With pREset

Time frame: during intervention, up to 3 hr

Population: 100 patients harboured 109 vessel occlusions

ArmMeasureValue (MEAN)Dispersion
All PatientsNo. of Passages Needed to Reach the Final TICI Score With pREset1.7 passesStandard Deviation 0.96
Secondary

Recanalization of the Target Vessel

original Thrombolysis in Cerebral Infarction score (o-TICI) The TICI scale indicates perfusion of an occluded blood vessel, it is used in angiographic imaging. Grade 0 = no perfusion Grade 1 = Penetration with minimal perfusion. The contrast material passes beyond the area of obstruction but fails to opacify the entire cerebral bed distal to the obstruction for the duration of the angiographic run, Grade 2a = Only partial filling (\<2/3) of the entire vascular territory is visualized, Grade 2b = Complete filling of all of the expected vascular territory is visualized, but the filling is slower than normal, Grade 3 = complete perfusion.

Time frame: at the end of intervention, up to 3 hr

Population: 100 patients harboured 109 vessel occlusions

ArmMeasureGroupValue (NUMBER)
All PatientsRecanalization of the Target VesselTICI 2b40 number of vessels
All PatientsRecanalization of the Target VesselTICI 07 number of vessels
All PatientsRecanalization of the Target VesselTICI 12 number of vessels
All PatientsRecanalization of the Target VesselTICI 2a8 number of vessels
All PatientsRecanalization of the Target VesselTICI 352 number of vessels
Secondary

Time From Groin Puncture to Recanalization

Time frame: during intervention, up to 3 hr

Population: All Patients

ArmMeasureValue (MEDIAN)
All PatientsTime From Groin Puncture to Recanalization40 minutes

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026